Literature DB >> 8258341

Expressed human immunoglobulin kappa genes and their hypermutation.

R Klein1, R Jaenichen, H G Zachau.   

Abstract

The question of which germ-line V kappa genes are expressed was studied by sequencing 70 different cDNA clones from a human spleen library and one clone from a fetal liver library. The sequences were compared to a data base containing all germ-line V kappa gene and pseudogene sequences. In addition, 51 rearranged genomic V kappa genes, 170 cDNA and 74 kappa proteins from the literature were assigned to specific germ-line V kappa genes and included in the comparisons. Not all the known, potentially functional V kappa genes were found to be expressed, while some genes with minor defects are. The total number of expressed genes is smaller than expected: so far 21 germ-line genes and 5 pairs of duplicated identical genes are known to be transcribed. The corresponding numbers for rearranged genomic V kappa genes and kappa proteins are 17 plus 4 and 7 plus 7, respectively. A second aim of the study was to find out whether the expressed repertoire contains derivatives of germ-line V kappa genes still missing in our data base; no evidence for the existence of such genes was found. Several cDNA clones contained additional nucleotides between the V kappa and J kappa gene segments, which may be germ-line derived, inserted by terminal deoxynucleotidyl transferase or introduced by other mechanisms. Somatic gene conversion seems not to play a major role in creating the human kappa gene diversity. Various aspects of the hypermutation of kappa genes are discussed and the formation of block mutations, i.e. the alterations of two or more adjacent nucleotides is stressed as a remarkable feature of the process.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8258341     DOI: 10.1002/eji.1830231231

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  35 in total

1.  Age-related alterations of somatic hypermutation and CDR3 lengths in human Vkappa4-expressing B lymphocytes.

Authors:  D Troutaud; M Drouet; C Decourt; C Le Morvan; M Cogné
Journal:  Immunology       Date:  1999-06       Impact factor: 7.397

2.  Somatic mutations of the L12a gene in V-kappa(1) light chain deposition disease: potential effects on aberrant protein conformation and deposition.

Authors:  R Vidal; F Goñi; F Stevens; P Aucouturier; A Kumar; B Frangione; J Ghiso; G Gallo
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

Review 3.  Factors that influence formation of B cell repertoire.

Authors:  A J Feeney
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

4.  Physicochemical consequences of amino acid variations that contribute to fibril formation by immunoglobulin light chains.

Authors:  R Raffen; L J Dieckman; M Szpunar; C Wunschl; P R Pokkuluri; P Dave; P Wilkins Stevens; X Cai; M Schiffer; F J Stevens
Journal:  Protein Sci       Date:  1999-03       Impact factor: 6.725

5.  Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia.

Authors:  Fabio Ghiotto; Franco Fais; Angelo Valetto; Emilia Albesiano; Shiori Hashimoto; Mariella Dono; Hideyuki Ikematsu; Steven L Allen; Jonathan Kolitz; Kanti R Rai; Marco Nardini; Anna Tramontano; Manlio Ferrarini; Nicholas Chiorazzi
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

Review 6.  B cell superantigens: a microbe's answer to innate-like B cells and natural antibodies.

Authors:  Carl S Goodyear; Gregg J Silverman
Journal:  Springer Semin Immunopathol       Date:  2005-03

7.  Differences in potential for amino acid change after mutation reveals distinct strategies for kappa and lambda light-chain variation.

Authors:  Uri Hershberg; Mark J Shlomchik
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-12       Impact factor: 11.205

8.  Molecular single-cell analysis reveals that CD5-positive peripheral blood B cells in healthy humans are characterized by rearranged Vkappa genes lacking somatic mutation.

Authors:  M Fischer; U Klein; R Küppers
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

9.  Molecular determinants of the human antibody response to HIV-1: implications for disease control.

Authors:  M Viau; M Zouali
Journal:  J Clin Immunol       Date:  2001-11       Impact factor: 8.317

10.  Analysis of human VH gene repertoire expression in peripheral CD19+ B cells.

Authors:  C Demaison; D David; F Letourneur; J Thèze; S Saragosti; M Zouali
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.